Fluoxetine in Depressed AUD Adolescents: A 1-Year Follow-up Evaluation
The DOI matches its Crossref record.
Abstract
The authors conducted the first naturalistic 1-year follow-up evaluation of 10 adolescents with comorbid major depressive disorder and an alcohol use disorder (AUD) who had previously participated in an acute phase study of open-label fluoxetine plus psychotherapy (Cornelius et al. 2001). The goal of this follow-up evaluation was to determine whether the decreases in drinking and in depressive symptoms that were noted during the acute phase study persisted at the follow-up evaluation. At the 1-year follow-up evaluation, the group continued to demonstrate significantly fewer depressive symptoms (according to the 24-item Hamilton Rating Scale for Depression) and a lower frequency of drinking (drinking days in the last 30 days) than they had demonstrated at the baseline of the acute phase study. Surprisingly, all of the subjects had chosen to discontinue their antidepressant medication by the second month of their naturalistic follow-up period. Three subjects had experienced a relapse of their major depression during the follow-up period, and three others demonstrated a persistence of their original depressive episode throughout the follow-up period. Also, the number of drinks per drinking day continued to be high (about five per day), which was not significantly different from the baseline level. Thus, the long-term therapeutic effects of an acute phase trial of fluoxetine plus psychotherapy were limited. The high rate of recurrence or persistence of major depression in our sample and in a previous sample of nonalcoholic adolescents with major depression (Emslie et al. 1998) and the significant levels of drinking of our comorbid adolescents suggest that longer term treatment may be needed for at least some adolescents with major depressive disorder and alcohol use disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Santisteban, D. A., Mena, M. P., Muir, J., McCabe, B. E., Abalo, C., & Cummings, A. M. (2015) · Psychiatric Rehabilitation Journal · doi:10.1037/prj0000106 · Cited by 49
Beaulieu, S., Saury, S., Sareen, J., Tremblay, J., Schütz, C. G., McIntyre, R. S., & Schaffer, A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400105 · Cited by 38
“52-54 However, results of a 12-week, double-blind, placebo-controlled RCT of fluoxetine vs placebo in that same adolescent population with comorbid MDD and AUD (N = 50), demonstrated no significant superiority of fluoxetine for treating either the depressive symptoms or the alcohol use behaviors…”
Beck Depression Inventory for depression screening in substance-abusing adolescents
Subramaniam, G., Harrell, P., Huntley, E., & Tracy, M. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.09.008 · Cited by 33
Treatments for Co-Occurring Depression and Substance Use in Young People: A Systematic Review
Deady, M., Teesson, M., & Kay-Lambkin, F. (2014) · Current Drug Abuse Reviews · doi:10.2174/1874473707666141015220608 · Cited by 25
“Five follow-up and case study papers from a single cohort study [93-97] were linked with the original paper as per Higgins and Green [85].”
Method
Metadata
- Authors
- Cornelius, J. R., Bukstein, O. G., Salloum, I. M., Kelly, T. M., Wood, D. S., & Clark, D. B.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2004-03
- Volume
- 14
- Issue
- 1
- Pages
- 33-38
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2033689100
- Cited by
- 23
- References
- 0
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluoxetine in Depressed AUD Adolescents: A 1-Year Follow-up Evaluation. https://app.cochat.ai/papers/10.1089/104454604773840463
- The paper
- Cornelius, J. R., Bukstein, O. G., Salloum, I. M., Kelly, T. M., Wood, D. S., & Clark, D. B. (2004). Fluoxetine in Depressed AUD Adolescents: A 1-Year Follow-up Evaluation. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/104454604773840463
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.